SEC Form 4 · accession 0001209191-15-068678
DYNAVAX TECHNOLOGIES CORP · DVAX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Coffman
Officer — Chief Scientific Officer & SVP
Period of report
Aug 27, 2015
Accepted (ET)
Aug 31, 2015 · 5:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001029142
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (Right to Buy)F2,F1 | $28.45 | Aug 27, 2015 | A | 16,501 | A | — | Aug 26, 2025 | Common Stock | 16,501 | 16,501 | D |
Explanation of responses
- F1This option grant will vest over four (4) years with one fourth (1/4) of the shares subject to vesting twelve months after the grant date, and one forty-eighth (1/48) of the shares subject to the option vesting on the last day of each month thereafter.
- F2Not applicable.